The change in gut microbiota promotes the development of non-alcoholic fatty liver disease by facilitating processes of inflammation, insulin resistance, bile acids and choline metabolism, changing intestinal permeability, production of ethanol in the intestine and interaction with innate immunity [55,58]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.